Nanosciences and Nanotechnology

Cancer Nanotechnology and Targeted Therapeutics

Further discussions may cover nano-immunotherapy, checkpoint delivery, cancer vaccines, and modulation of the tumour microenvironment to improve immune response. Presentations will examine radiotherapy enhancement, radiosensitisation, and boron neutron capture approaches. Researchers will consider theranostic nanoparticles that combine treatment with real-time monitoring, and antibody–drug conjugates engineered at the nanoscale. Attention will be given to adverse effects, off-target accumulation in liver and spleen, and immune-related toxicity. Biomarker-driven patient selection and imaging-guided dosing will be reviewed. Registries, real-world evidence, and transparent reporting standards for nanomedicine trials will be encouraged.